Valuation: Balchem Corporation

Market Cap 5.21B 4.56B 4.2B 3.88B 7.37B 497B 7.49B 50.22B 19.72B 245B 19.56B 19.14B 842B P/E 2026 *
31.2x
P/E 2027 * 30.2x
Enterprise Value 5.2B 4.55B 4.19B 3.87B 7.35B 496B 7.47B 50.11B 19.68B 244B 19.52B 19.09B 840B EV / Sales 2026 *
4.69x
EV / Sales 2027 * 4.33x
Free-Float
99.53%
Yield 2026 *
0.7%
Yield 2027 * 0.78%
1 day-0.84%
1 week-3.94%
Current month-4.02%
1 month-1.75%
3 months-7.31%
6 months+1.85%
Current year+5.73%
1 week 161.91
Extreme 161.91
168.74
1 month 161.91
Extreme 161.91
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 61.03
Extreme 61.03
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Controller/Auditor

8,646 0.0270%
02-10Free

Head of Human Resources

8,685 0.0268%
02-10Free

Chief Executive Officer

62,743 0.1937%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-3.94%+2.34%+23.31% 5.21B
+0.47%-3.19%+2.75%+46.86% 77.2B
+0.41%-2.11%-9.42%+14.17% 39.27B
+0.99%-6.81%-21.00%-35.98% 32.36B
-0.31%-1.35%+19.32%+30.99% 26.33B
-1.21%+0.67%+94.50%-8.71% 20.91B
+4.24%+2.22%+10.88%+2.96% 20.68B
-0.08%-3.74%-40.53%-38.19% 18.18B
-1.85%-7.02%+77.59%-48.22% 14.87B
+0.07%-3.02%-1.20%-7.59% 13.94B
Average +0.18%-2.79%+13.52%-2.04% 26.9B
Weighted average by Cap. +0.39%-2.79%+8.49%+8.59%

Financials

2026 *2027 *
Net sales 1.11B 969M 894M 826M 1.57B 106B 1.59B 10.68B 4.2B 52.07B 4.16B 4.07B 179B 1.17B 1.02B 941M 870M 1.65B 111B 1.68B 11.25B 4.42B 54.82B 4.38B 4.29B 188B
Net income 168M 147M 136M 125M 238M 16.04B 242M 1.62B 637M 7.9B 632M 618M 27.17B 174M 152M 140M 129M 246M 16.57B 250M 1.68B 658M 8.17B 653M 638M 28.07B
Net Debt -11.86M -10.38M -9.57M -8.84M -16.77M -1.13B -17.05M -114M -44.9M -557M -44.54M -43.57M -1.92B -153M -134M -124M -114M -217M -14.62B -220M -1.48B -580M -7.2B -576M -563M -24.76B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
26-07-10 US$162.15 -0.84% 249,120
26-07-09 US$163.53 -1.49% 256,170
26-07-08 US$166.01 -1.25% 285,515
26-07-07 US$168.11 +0.66% 278,924
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
162.15USD
Average target price
200.75USD
Spread / Average Target
+23.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock